These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8396525)

  • 21. Heparin therapy in fulminant meningococcemia.
    Najjar SS; Ahmad M
    J Pediatr; 1969 Sep; 75(3):449-53. PubMed ID: 5804192
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.
    Kornelisse RF; Hazelzet JA; Savelkoul HF; Hop WC; Suur MH; Borsboom AN; Risseeuw-Appel IM; van der Voort E; de Groot R
    J Infect Dis; 1996 May; 173(5):1148-56. PubMed ID: 8627066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fulminant meningococcemia treated with antiendotoxin IgM monoclonal antibodies (HA-1A)].
    Gómez-Jiménez J; Peracaula Picart R; Jódar Masanes R; Montoro Ronsano B
    Med Clin (Barc); 1993 Mar; 100(10):394-5. PubMed ID: 8474285
    [No Abstract]   [Full Text] [Related]  

  • 24. Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections.
    van Deuren M; Netea MG; Hijmans A; Demacker PN; Neeleman C; Sauerwein RW; Bartelink AK; van der Meer JW
    J Infect Dis; 1998 May; 177(5):1401-5. PubMed ID: 9593034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Meningococcal infection submitted to treatment. Subdural spinal hematoma].
    Diaz-Aramendi A; Paniagua JL; Hernandez J; Maillo A; Jimenez-Lopez A; de Castro S
    Neurochirurgie; 1973 Dec; 19(7):641-8. PubMed ID: 4792192
    [No Abstract]   [Full Text] [Related]  

  • 26. [Meningococcal disease in the province of Córdoba (1983-1987].
    Martínez de la Iglesia J; Montero Pérez FJ; Fernández-Crehuet Navajas R
    Enferm Infecc Microbiol Clin; 1990; 8(7):420-5. PubMed ID: 2152477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.
    Powars D; Larsen R; Johnson J; Hulbert T; Sun T; Patch MJ; Francis R; Chan L
    Clin Infect Dis; 1993 Aug; 17(2):254-61. PubMed ID: 8399877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipids or apolipoprotein A-I and disease severity of meningococcal sepsis.
    Chenaud C; Merlani PG; Bandshapp O; Ricou B
    Crit Care Med; 2006 Jan; 34(1):270-1. PubMed ID: 16374207
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current problems in the corticosteroid- and heparin therapy of peracute miningococcal infections].
    Wendler H; Falk W
    Wien Med Wochenschr; 1971 Aug; 121(33):609-11. PubMed ID: 5115494
    [No Abstract]   [Full Text] [Related]  

  • 30. Early meningococcal disease: advising the public and the profession.
    Peltola H
    Lancet; 1993 Aug; 342(8870):509-10. PubMed ID: 8102663
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged mild meningococcemia in children].
    Arrøe M
    Ugeskr Laeger; 1983 Oct; 145(43):3342-4. PubMed ID: 6659104
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
    Zenz W; Muntean W; Gallistl S; Zobel G; Grubbauer HM
    Pediatrics; 1995 Jul; 96(1 Pt 1):144-8. PubMed ID: 7596694
    [No Abstract]   [Full Text] [Related]  

  • 33. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cortisol in children with fulminating meningococcal infection.
    Zachmann M; Fanconi A; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):245-50. PubMed ID: 4369019
    [No Abstract]   [Full Text] [Related]  

  • 35. [Functional condition of the blood coagulation system in patients with meningococcemia with a shock].
    Lisukova TE; Cherniaeva TS
    Klin Med (Mosk); 1973 Apr; 51(4):120-5. PubMed ID: 4704251
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment and prevention in meningococcal infections].
    Niklasson PM
    Lakartidningen; 1976 Mar; 73(13):1217-9. PubMed ID: 1263641
    [No Abstract]   [Full Text] [Related]  

  • 37. Meningococcemia in vaccinated patient under treatment with eculizumab.
    Hernando Real S; Vega Castaño S; Pajares García R
    Enferm Infecc Microbiol Clin; 2017 Mar; 35(3):200-201. PubMed ID: 26994815
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity.
    Gårdlund B; Sjölin J; Nilsson A; Roll M; Wickerts CJ; Wretlind B
    J Infect Dis; 1995 Jul; 172(1):296-301. PubMed ID: 7797935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fever with a rash caused by chronic meningococcemia].
    de Jonge JC; Koop K; Bousema M; Nuboer R
    Ned Tijdschr Geneeskd; 2015; 159():A8103. PubMed ID: 25850448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
    Girardin E; Roux-Lombard P; Grau GE; Suter P; Gallati H; Dayer JM
    Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.